Go Pro

Tenet Healthcare (THC) Stock Price, News & Analysis

Tenet Healthcare logo
$274.06 +2.18 (+0.80%)
As of 03:58 PM Eastern

About Tenet Healthcare Stock (NYSE:THC)

Advanced

Key Stats

Today's Range
$272.06
$278.16
50-Day Range
$172.63
$280.60
52-Week Range
$157.58
$283.05
Volume
513,308 shs
Average Volume
1.23 million shs
Market Capitalization
$22.07 billion
P/E Ratio
10.57
Dividend Yield
N/A
Price Target
$273.00
Consensus Rating
Buy

Company Overview

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination. These services include physician practice partnerships and networks, outpatient surgery and imaging services, and programs aimed at enhancing clinical quality, patient experience and operational efficiency. The company works with payors, health systems and physicians to implement care models that address both fee-for-service and value-based reimbursement environments.

Headquartered in Dallas, Texas, Tenet’s facilities and services are concentrated across the United States. The company has grown and evolved through a combination of facility development, acquisitions and strategic partnerships to expand its geographic footprint and service offerings. Tenet continues to invest in clinical programs, technology and care delivery models intended to advance outcomes and access for the communities it serves while navigating the regulatory and market dynamics of the U.S. healthcare system.

AI Generated. May Contain Errors.

Tenet Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

THC MarketRank™: 

Tenet Healthcare scored higher than 60% of companies evaluated by MarketBeat, and ranked 459th out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tenet Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 19 buy ratings, 1 hold rating, and no sell ratings.

  • Upside/Downside

    The consensus price target for Tenet Healthcare is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Tenet Healthcare has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Tenet Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Tenet Healthcare are expected to decrease by -3.24% in the coming year, from $20.98 to $20.30 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tenet Healthcare is 10.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.21.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tenet Healthcare is 10.59, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.55.

  • Price to Earnings Growth Ratio

    Tenet Healthcare has a PEG Ratio of 1.07. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Tenet Healthcare has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Tenet Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    3.16% of the float of Tenet Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenet Healthcare has a short interest ratio ("days to cover") of 3.11, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tenet Healthcare has recently decreased by 21.20%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tenet Healthcare does not currently pay a dividend.

  • Dividend Growth

    Tenet Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Tenet Healthcare has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Tenet Healthcare this week, compared to 6 articles on an average week.
  • Search Interest

    Only 12 people have searched for THC on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Tenet Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tenet Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,793,347.00 in company stock.

  • Percentage Held by Insiders

    0.97% of the stock of Tenet Healthcare is held by insiders.

  • Percentage Held by Institutions

    95.44% of the stock of Tenet Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Tenet Healthcare's insider trading history.
Receive THC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenet Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THC Stock News Headlines

Tenet Healthcare (NYSE:THC) Reaches New 12-Month High - Should You Buy?
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money network by April 2027. BlackRock CEO Larry Fink already calls it 'the next major evolution in market infrastructure.' Our research has identified one small, overlooked position at the center of this policy-driven shift - already drawing quiet institutional buying from BNY Mellon, State Street, and JPMorgan. It currently trades for pennies relative to where institutional demand could push it. The Q3 2026 compliance deadline may be the last window before prices move.tc pixel
See More Headlines

THC Stock Analysis - Frequently Asked Questions

Tenet Healthcare's stock was trading at $198.75 at the beginning of the year. Since then, THC shares have increased by 38.2% and is now trading at $274.71.

Tenet Healthcare Corporation (NYSE:THC) announced its earnings results on Thursday, July, 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. The firm's quarterly revenue was up 6.8% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Tenet Healthcare: SurgCenter Development, United Surgical Partners International, European Surgical Partners Ltd., Aspen Healthcare, Emanuel Medical Center, Texas Regional Medical in Sunnyvale, Vanguard Health Systems, and others.

Tenet Healthcare's top institutional shareholders include California State Teachers Retirement System (23.45%), Manning & Napier Advisors LLC (1.12%), Bank of New York Mellon Corp (0.66%) and Wedge Capital Management L L P NC (0.26%). Insiders that own company stock include Saumya Sutaria, James L Bierman, Richard J Mark, Lisa Y Foo, Tammy Romo, Nadja West, Paola M Arbour, J Robert Kerrey, Meghan Fitzgerald, Christopher S Lynch, Richard W Fisher, Roy Blunt, Thomas W Arnst and R Scott Ramsey.
View institutional ownership trends
.

Shares of THC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenet Healthcare investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
7/23/2026
Today
8/26/2026
Next Earnings (Estimated)
10/27/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NYSE:THC
CIK
70318
Employees
99,000
Year Founded
1969

Price Target and Rating

High Price Target
$308.00
Low Price Target
$225.00
Potential Upside/Downside
-0.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
21 Analysts

Profitability

EPS (Trailing Twelve Months)
$25.93
Trailing P/E Ratio
10.57
Forward P/E Ratio
13.06
P/E Growth
1.07
Net Income
$1.41 billion
Net Margins
10.27%
Pretax Margin
17.72%
Return on Equity
26.76%
Return on Assets
5.55%

Debt

Debt-to-Equity Ratio
2.00
Current Ratio
1.41
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$21.31 billion
Price / Sales
1.04
Cash Flow
$27.27 per share
Price / Cash Flow
10.05
Book Value
$81.43 per share
Price / Book
3.37

Miscellaneous

Outstanding Shares
80,520,000
Free Float
79,738,000
Market Cap
$22.07 billion
Optionable
Optionable
Beta
1.23

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NYSE:THC) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners